Learn More
CD268 (BAFF-R) Rat anti-Mouse, BUV395, Clone: 7H22-E16, BD Optibuild™
Shop All BD Biosciences ProductsDescription
The 7H22-E16 monoclonal antibody specifically binds to CD268, which is also known as, B cell-activating factor receptor (BAFF-R), or BAFF Receptor 3 (BR3). CD268 is a type III transmembrane protein that is likewise known as Tumor necrosis factor receptor superfamily member 13C (Tnfrsf13c). CD268/BAFF-R is a receptor for CD257 (also known as, BAFF, Blys, TALL-1, or THANK) and is expressed on B cells and a subset of activated/memory CD4+ T cells. B cells express two other BAFF receptors, CD267/TACI, or CD269/BCMA, at various times during their differentiation. CD268/BAFF-R expression starts at the transitional stage of B cell development and increases throughout B cell maturation. CD267/BAFF-R mediates most BAFF-dependent functions including B cell survival, the activation of B cell proliferation and immunoglobulin secretion, and the costimulation of T cells. Overexpression of BAFF in mice and humans is associated with autoimmunity, whereas CD268/BAFF-R deficiency may cause severe impairment in humoral responses.
Specifications
Specifications
| Antigen | CD268 (BAFF-R) |
| Classification | Monoclonal |
| Clone | 7H22-E16 |
| Concentration | 0.2mg/mL |
| Conjugate | Brilliant Ultraviolet 395 |
| Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
| Gene Alias | Tnfrsf13c, TR13C, BAFF-R, Baffr, Bcmd, Bcmd-1, BLyS receptor 3, Br3, Lvis22 |
| Host Species | Rat |
| Immunogen | Mouse BAFF-R Recombinant Protein |
| Purification Method | Affinity Purified |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.